Literature DB >> 1741143

Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to giant-cell arteritis.

D C Matzkin1, T L Slamovits, R Sachs, R M Burde.   

Abstract

Two patients with central retinal artery occlusions secondary to biopsy-proven giant-cell arteritis lost visual acuity to no light perception but recovered to baseline acuity after treatment with intravenous methylprednisolone at a dose of 15 to 30 mg/kg/day. The potential advantages and theoretical basis of early and aggressive treatment with large-dose intravenous corticosteroids in arteritic central retinal artery occlusion are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1741143     DOI: 10.1016/s0161-6420(92)32009-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  Heparin therapy in giant cell arteritis.

Authors:  L M Buono; R Foroozan; M de Virgiliis; P J Savino
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

2.  Isolated central retinal artery occlusion as an initial presentation of paroxysmal nocturnal hemoglobinuria and successful long-term prevention of systemic thrombosis with eculizumab.

Authors:  Hyun Seung Yang; So Hyun Park; Jung Ran Choi; June-Gone Kim
Journal:  Jpn J Ophthalmol       Date:  2013-06-14       Impact factor: 2.447

3.  Giant Cell Arteritis.

Authors:  Jennifer K. Hall; Laura J. Balcer
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

4.  Development of an evidence-based regimen of prednisolone to treat giant cell arteritis - the Norwich regimen.

Authors:  Chetan Mukhtyar; Heidi Cate; Conor Graham; Peter Merry; Karen Mills; Aseema Misra; Colin Jones
Journal:  Rheumatol Adv Pract       Date:  2019-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.